Beam Therapeutics Inc. (BMV:BEAM)
Mexico
· Delayed Price · Currency is MXN 461.00
0.00 (0.00%)
At close: Dec 3, 2025
Beam Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Cash & Equivalents | 267.96 | 281.97 | 435.9 | 232.77 | 559.99 | 162.17 | Upgrade
|
| Short-Term Investments | 807.01 | 568.77 | 753.98 | 845.37 | 405.65 | 137.5 | Upgrade
|
| Cash & Short-Term Investments | 1,075 | 850.74 | 1,190 | 1,078 | 965.65 | 299.67 | Upgrade
|
| Cash Growth | 16.12% | -28.50% | 10.36% | 11.65% | 222.24% | 226.27% | Upgrade
|
| Receivables | - | - | - | - | 300 | - | Upgrade
|
| Prepaid Expenses | 23.58 | 27.41 | 21.17 | 14.76 | 7.36 | 8.65 | Upgrade
|
| Total Current Assets | 1,099 | 878.15 | 1,211 | 1,093 | 1,273 | 308.32 | Upgrade
|
| Property, Plant & Equipment | 205.29 | 216.28 | 237.81 | 234.13 | 186.98 | 125.37 | Upgrade
|
| Other Long-Term Assets | 7.25 | 9.4 | 10.87 | 14.69 | 14.47 | 17.98 | Upgrade
|
| Total Assets | 1,311 | 1,104 | 1,460 | 1,342 | 1,474 | 451.68 | Upgrade
|
| Accounts Payable | 9.55 | 3.87 | 1.62 | 9.03 | 7.47 | 6.31 | Upgrade
|
| Accrued Expenses | 36.29 | 36.13 | 35.05 | 30.72 | 56.87 | 11.96 | Upgrade
|
| Current Portion of Leases | 12.69 | 13.47 | 12.78 | 12.23 | 9.83 | 6.34 | Upgrade
|
| Current Unearned Revenue | 110.32 | 108.86 | 68.71 | 135.97 | 86.27 | 0.02 | Upgrade
|
| Other Current Liabilities | 13.72 | 19.74 | 87.42 | 35.64 | 53 | 77.7 | Upgrade
|
| Total Current Liabilities | 182.56 | 182.07 | 205.57 | 223.6 | 213.44 | 102.34 | Upgrade
|
| Long-Term Leases | 138.73 | 147.96 | 159.91 | 168.63 | 137.82 | 101.31 | Upgrade
|
| Long-Term Unearned Revenue | 10.16 | 33.22 | 109.89 | 202.18 | 262.3 | 0.39 | Upgrade
|
| Other Long-Term Liabilities | 13.63 | 7.04 | 3.02 | 13.84 | 34.16 | 2.08 | Upgrade
|
| Total Liabilities | 345.08 | 370.28 | 478.39 | 608.24 | 647.72 | 206.12 | Upgrade
|
| Common Stock | 1.01 | 0.84 | 0.82 | 0.71 | 0.68 | 0.57 | Upgrade
|
| Additional Paid-In Capital | 2,855 | 2,299 | 2,170 | 1,793 | 1,594 | 642.63 | Upgrade
|
| Retained Earnings | -1,891 | -1,567 | -1,190 | -1,057 | -768.27 | -397.64 | Upgrade
|
| Comprehensive Income & Other | 0.79 | 0.68 | 0.6 | -2.43 | -0.05 | -0.01 | Upgrade
|
| Total Common Equity | 966 | 733.55 | 981.33 | 733.47 | 826.74 | 245.56 | Upgrade
|
| Shareholders' Equity | 966 | 733.55 | 981.33 | 733.47 | 826.74 | 245.56 | Upgrade
|
| Total Liabilities & Equity | 1,311 | 1,104 | 1,460 | 1,342 | 1,474 | 451.68 | Upgrade
|
| Total Debt | 151.42 | 161.43 | 172.69 | 180.86 | 147.64 | 107.64 | Upgrade
|
| Net Cash (Debt) | 923.55 | 689.32 | 1,017 | 897.28 | 818 | 192.03 | Upgrade
|
| Net Cash Growth | 20.93% | -32.23% | 13.36% | 9.69% | 325.98% | 216.82% | Upgrade
|
| Net Cash Per Share | 9.84 | 8.37 | 13.18 | 12.82 | 12.74 | 4.11 | Upgrade
|
| Filing Date Shares Outstanding | 98.69 | 81.11 | 78.73 | 70.7 | 67.6 | 61.14 | Upgrade
|
| Total Common Shares Outstanding | 98.58 | 81.06 | 78.71 | 69.58 | 67.26 | 55.98 | Upgrade
|
| Working Capital | 915.99 | 696.08 | 1,005 | 869.3 | 1,060 | 205.98 | Upgrade
|
| Book Value Per Share | 9.80 | 9.05 | 12.47 | 10.54 | 12.29 | 4.39 | Upgrade
|
| Tangible Book Value | 966 | 733.55 | 981.33 | 733.47 | 826.74 | 245.56 | Upgrade
|
| Tangible Book Value Per Share | 9.80 | 9.05 | 12.47 | 10.54 | 12.29 | 4.39 | Upgrade
|
| Machinery | 84.41 | 79.79 | 69.67 | 54.79 | 35.23 | 18.83 | Upgrade
|
| Construction In Progress | 10.24 | 2.53 | 5.28 | 5.2 | 7.35 | 15.88 | Upgrade
|
| Leasehold Improvements | 102.25 | 101.2 | 100.19 | 85.8 | 57.76 | 12.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.